The Discounted Cash Flow (DCF) valuation of Amneal Pharmaceuticals Inc (AMRX) is 11.53 USD. With the latest stock price at 8.41 USD, the upside of Amneal Pharmaceuticals Inc based on DCF is 37.1%.
Based on the latest price of 8.41 USD and our DCF valuation, Amneal Pharmaceuticals Inc (AMRX) is a buy. buying Amneal stocks now will result in a potential gain of 37.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 10.4% | 8.2% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 4.04 - 47.82 | 11.53 |
| Upside | -51.9% - 468.6% | 37.1% |